Passage of the comprehensive immunosuppressive drug coverage for kidney transplant patients act-a chance to celebrate and reflect

John S. Gill; Richard N. Formica; Barbara Murphy

doi:10.1681/ASN.2020121811

Passage of the comprehensive immunosuppressive drug coverage for kidney transplant patients act-a chance to celebrate and reflect

John S. Gill
, Richard N. Formica
, Barbara Murphy

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	774-776
Number of pages	3
Journal	Journal of the American Society of Nephrology
Volume	32
Issue number	4
DOIs	https://doi.org/10.1681/ASN.2020121811
State	Published - Apr 2021

Access to Document

10.1681/ASN.2020121811

Cite this

@article{152a42af58df47fbbf62645beef4ef17,

title = "Passage of the comprehensive immunosuppressive drug coverage for kidney transplant patients act-a chance to celebrate and reflect",

author = "Gill, \{John S.\} and Formica, \{Richard N.\} and Barbara Murphy",

note = "Funding Information: R.N. Formica is president of the American Society of Transplantation; reports consultancy agreements with Gennentech, Malinkrodt Pharmaceuticals, and Veloxis Pharmaceuticals; other interests/relationships as president of American Society of Transplantation and as a member of the UNOS/OPTN Membership and Professional Standards Committee. J.S. Gill is president elect of the American Society of Transplantation; is supported by a Foundation Award from the Canadian Institutes of Health Research; has received research funding from Astellas; and reports being a scientific advisor or membership with the Declaration of Istanbul Custodial Group. B. Murphy is councilor of the American Society of Nephrology and past president of the American Society of Transplantation; reports consultancy agreements with RenalytixAI and Verici Dx; ownership interest in Renalytix AI and Verici Dx; research funding from NIH; honoraria from University of Virginia and Yale; patents and inventions from Verici Dx; scientific advisor or board membership of Linus, Trelus, RenalytixAI, Veloxis, and Vertex.",

year = "2021",

month = apr,

doi = "10.1681/ASN.2020121811",

language = "English",

volume = "32",

pages = "774--776",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Passage of the comprehensive immunosuppressive drug coverage for kidney transplant patients act-a chance to celebrate and reflect

AU - Gill, John S.

AU - Formica, Richard N.

AU - Murphy, Barbara

N1 - Funding Information: R.N. Formica is president of the American Society of Transplantation; reports consultancy agreements with Gennentech, Malinkrodt Pharmaceuticals, and Veloxis Pharmaceuticals; other interests/relationships as president of American Society of Transplantation and as a member of the UNOS/OPTN Membership and Professional Standards Committee. J.S. Gill is president elect of the American Society of Transplantation; is supported by a Foundation Award from the Canadian Institutes of Health Research; has received research funding from Astellas; and reports being a scientific advisor or membership with the Declaration of Istanbul Custodial Group. B. Murphy is councilor of the American Society of Nephrology and past president of the American Society of Transplantation; reports consultancy agreements with RenalytixAI and Verici Dx; ownership interest in Renalytix AI and Verici Dx; research funding from NIH; honoraria from University of Virginia and Yale; patents and inventions from Verici Dx; scientific advisor or board membership of Linus, Trelus, RenalytixAI, Veloxis, and Vertex.

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85105032969

U2 - 10.1681/ASN.2020121811

DO - 10.1681/ASN.2020121811

M3 - Review article

C2 - 33653687

AN - SCOPUS:85105032969

SN - 1046-6673

VL - 32

SP - 774

EP - 776

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 4

ER -